Taiwan Bio Therapeutics Co., Ltd
6892
Rank in Stocks
#21101
Taiwan Bio Therapeutics Co., Ltd. is an enterprise specializing in regenerative... Taiwan Bio Therapeutics Co., Ltd. is an enterprise specializing in regenerative medicine, primarily dedicated to the development of novel cellular therapeutics. These advanced treatments are crafted to address a range of medical conditions, including degenerative disorders, cardiovascular ailments, complications stemming from diabetes, and autoimmune diseases. The company was established in 2014 and its operations are headquartered in Taipei City, Taiwan.
Share Price
$0.78040214
Last synced: 2026-11-10
Market Cap
$73.37M
Change (1 day)
-0.58%
Change (1 year)
-18.15%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Taiwan Bio Therapeutics Co., Ltd (6892)
Category
Healthcare
EPS for Taiwan Bio Therapeutics Co., Ltd (6892)
EPS as of June 2025 TTM: $-0.18
According to Taiwan Bio Therapeutics Co., Ltd's latest financial reports, its current EPS (TTM) is $-0.18. At the end of 2025 the company had an EPS of $-0.14, equal to its 2024 EPS of $-0.14.
EPS history for Taiwan Bio Therapeutics Co., Ltd from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.18 | 25.93% |
| 2025 | $-0.14 | -0.07% |
| 2024 | $-0.14 | 15.78% |
| 2023 | $-0.12 | 0.49% |
| 2022 | $-0.12 | 13.08% |
| 2021 | $-0.11 | -15.86% |
| 2020 | $-0.13 | 4.42% |
| 2019 | $-0.12 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -8,982.59% |
US
|
|
| $-7.07 | 3,910.21% |
US
|
|
| $-5.29 | 2,900.57% |
AU
|
|
| $12.88 | -7,405.79% |
BE
|
|
| $21.56 | -12,329.15% |
NL
|
Questions about Taiwan Bio Therapeutics Co., Ltd's earnings per share (EPS)
What is Taiwan Bio Therapeutics Co., Ltd's earnings per share (EPS)?
Taiwan Bio Therapeutics Co., Ltd's earnings per share (EPS) over the last twelve months is $-0.18, as of Jun 2025.
What was Taiwan Bio Therapeutics Co., Ltd's earnings per share (EPS) in 2025?
In 2025, Taiwan Bio Therapeutics Co., Ltd's earnings per share (EPS) was $-0.14, compared with $-0.14 in 2024.
How has Taiwan Bio Therapeutics Co., Ltd's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Taiwan Bio Therapeutics Co., Ltd's earnings per share (EPS) was highest in 2021 ($-0.11) and lowest in 2025 ($-0.14).
How does Taiwan Bio Therapeutics Co., Ltd's earnings per share (EPS) compare with similar companies?
Taiwan Bio Therapeutics Co., Ltd's earnings per share (EPS) ($-0.18) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.